Patara Pharma Raises $26M

San Diego-based Patara Pharma, a biopharmaceuticals company developing treatments for allergic and inflammatory diseases and conditions, said today that it has raised $26M in a Series A funding round. Sourec of the funding was not announced. In addition to the equity funding, Patara said it has also received a loan from Silicon Valley Bank of up to $7M. Patara's lead candidate is being aimed at treating refractory chronic cough and indolent systemic mastocytosis, particularly patients with idiopathic pulmonary fibrosis (IPF). More information »